Ubiquitin-conjugating enzyme 9 promotes epithelial ovarian cancer cell proliferation in Vitro

International Journal of Molecular Sciences

Volumn 14, Issue 6, 2013, Pages 11061-11071

  Dong, Mei ^a   Pang, Xiaoyan ^a   Xu, Yang ^a   Wen, Fang ^a   Zhang, Yi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Akt; Epithelial ovarian cancer (EOC); Proliferation; Ubiquitin conjugating enzyme 9 (Ubc9)

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ENHANCED GREEN FLUORESCENT PROTEIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME 9; UNCLASSIFIED DRUG; UBIQUITIN-CONJUGATING ENZYME UBC9;

ARTICLE; CANCER CELL; CELL ASSAY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GENE FUNCTION; GENE SILENCING; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; OVARY CARCINOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECOMBINANT PLASMID; SIGNAL TRANSDUCTION; UBC9 GENE; WESTERN BLOTTING; CELL CLONE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC RECOMBINATION; GENETICS; METABOLISM; NEOPLASM; OVARY TUMOR; PATHOLOGY; PLASMID;

CELL PROLIFERATION; CLONE CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PLASMIDS; PROTO-ONCOGENE PROTEINS C-AKT; RECOMBINATION, GENETIC; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; UBIQUITIN-CONJUGATING ENZYMES;

EID: 84878429253     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140611061     Document Type: Article

References (19)

1. Johnson, E.S.; Blobel, G. Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 1997, 272, 26799-26802.
2. Tashiro, K.; Pando, M.P.; Kanegae, Y.; Wamsley, P.M.; Inoue, S.; Verma, I. Direct involvement of the ubiquitin-conjugating enzyme Ubc9/Hus5 in the degradation of InBa. Proc. Natl. Acad. Sci. USA 1997, 94, 7862-7867.
3. Desterro, J.M.; Thomson, J.; Hay, R.T. Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 1997, 417, 297-300.
4. Geiss-Friedlander, R.; Melchior, F. Concepts in sumoylation: A decade on. Nat. Rev. Mol. Cell Biol. 2007, 8, 947-956.
5. Kurtzman, A.L.; Schechter, N. Ubc9 interacts with a nuclear localization signal and mediates nuclear localizationof the paired-like homeobox protein Vsx-1 independent of SUMO-1modification. Proc. Natl. Acad. Sci. USA 2001, 98, 5602-5607.
6. Kaul, S.; Blackford, J.A., Jr.; Cho, S.; Simons, S.S., Jr. Ubc9 is a novel modulator of the induction properties of glucocorticoid receptors. J. Biol. Chem. 2002, 277, 12541-12549.
7. Zhu, S.; Sachdeva, M.; Wu, F.; Lu, Z.; Mo, Y. Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner. Oncogene 2010, 29, 1763-1772.
8. Wu, F.; Zhu, S.; Ding, Y.; Beck, W.T.; Mo, Y. MicroRNA-mediated regulation of Ubc9 expression in cancer cells. Clin. Cancer Res. 2009, 15, 1550-1557.
9. Moschos, S.J.; Smith, A.P.; Mandic, M.; Athanassiou, C.; Watson-Hurst, K.; Jukic, D.M.; Edington, H.D.; Kirkwood, J.M.; Becker, D. SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanoma. Oncogene 2007, 26, 4216-4225.
10. Moschos, S.J.; Jukic, D.M.; Athanassiou, C.; Bhargava, R.; Dacic, S.; Wang, X.; Kuan, S.F.; Fayewicz, S.L.; Galambos, C.; Acquafondata, M.; et al. Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues. Hum. Pathol. 2010, 41, 1286-1298.
11. Chen, S.F.; Gong, C.; Luo, M.; Yao, H.R.; Zeng, Y.J.; Su, F.X. Ubc9 expression predicts chemoresistance in breast cancer. Chin. J. Cancer 2011, 30, 638-644.
12. Mo, Y.; Yu, Y.; Theodosiou, E.; Ee, P.L.R.; Beck, W.T. A role for Ubc9 in tumorigenesis. Oncogene 2005, 24, 2677-2683.
13. Melchior, F. SUMO-nonclassical ubiquitin. Annu. Rev. Cell Dev. Biol. 2000, 16, 591-626.
14. Muller, S.; Hoege, C.; Pyrowolakis, G.; Jentsch, S. SUMO, ubiquitin's mysterious cousin. Nat. Rev. Mol. Cell Biol. 2001, 2, 202-210.
15. Mo, Y.Y.; Moschos, S.J. Targeting Ubc9 for cancer therapy. Expert Opin. Ther. Targets 2005, 9, 1203-1216.
16. Woenckhaus, J.; Steger, K.; Sturm, K.; Münstedt, K.; Franke, F.E.; Fenic, I. Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer. Virchows. Archiv. 2007, 450, 387-395.
17. Qin, Y.; Xu, J.; Aysola, K.; Oprea, G.; Reddy, A.; Matthews, R.; Okoli, J.; Cantor, A.; Grizzle, W.E.; Partridge, E.E.; et al. BRCA1 proteins regulate growth of ovarian cancer cells by tethering Ubc9. Am. J. Cancer Res. 2012, 2, 540-548.
18. Do, T.V.; Kubba, L.A.; Antenos, M.; Rademaker, A.W.; Sturgis, C.D.; Woodruff, T.K. The role of activin A and Akt/GSK signaling in ovarian tumor biology. Endocrinology 2008, 149, 3809-3816.
19. Shtilbans, V.; Wu, M.; Burstein, D.E. Current overview of the role of Akt in cancer studies via applied immunohistochemistry. Annu. Diagn. Pathol. 2008, 12, 153-160.